| A Revolutionary Breakthrough |
|
If you are a man or women 18 to 58 years old, BIOMETRIX™ can make all the difference in your life.
A better career. Renewed confidence and all the
excitement you can handle. Unlike other companies
that basically offer the same hair loss treatments BIOMETRIX™ brings you the latest advances in FDA
reviewed scientific and natural tendency research
and application to prevent and cure the appearance
of thinning to extreme hair loss. |
| |
| There's No One Right Answer |
|
Recommended by leading physicians, hair stylists,
and hundreds of thousands of satisfied individuals the
world over. We use the most advanced scientific approach,
Follicular Microscopy Testing & Analysis (FMTA), to
determine the best possible treatment available.
Based on these results, we'll take the time to review
and discuss your best options from Inversion Cold Laser treatment to the latest in our intralacement, non-surgical
methods. The result. More natural, fuller, thicker and touchable hair....
your own! Experience how great life can be in just 24 hours. |
|
|
Results Without Pain or Discomfort. |
For those with early stage thinning, to those who have
had hair transplant surgery, our Inversion Cold Laser
treatment, (ICLT) has been demonstrated to prevent
further progression of hair loss in 93% of clients. ICLT
stimulates rehabilitation and rejuvination of hair follicles
promoting new growth and repairs and improves hair shaft
quality resulting in a 25% increase in thickness. A key result is in the reduction in excess levels of the skin
5 alpha reductase enzyme that produces dihydrotestosterone
(DHT) which contributes to genetic thinning of hair.
|
| For those that have experienced extreme hair loss or are
already living with some form of hair enhancement system,
our FDA approved intralacement, non-surgical methods
can offer you a level of confidence you may have never
experienced. You'll see and feel the results in less than
24 hours. Everyone else will only notice your new self
confidence and joy of living. |
| |
| |
|
|